SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $44,898,000 | +54.0% | 264,231 | +4.5% | 0.06% | +30.6% |
| Q1 2020 | $29,156,000 | +7.0% | 252,768 | +5.9% | 0.05% | +22.5% |
| Q4 2019 | $27,253,000 | +71.2% | 238,588 | +27.9% | 0.04% | +66.7% |
| Q3 2019 | $15,923,000 | +36.9% | 186,491 | +11.0% | 0.02% | +41.2% |
| Q2 2019 | $11,633,000 | +3.3% | 168,080 | +9.3% | 0.02% | 0.0% |
| Q1 2019 | $11,261,000 | +33.7% | 153,749 | +3.4% | 0.02% | +13.3% |
| Q4 2018 | $8,425,000 | -43.0% | 148,691 | -22.4% | 0.02% | -31.8% |
| Q3 2018 | $14,785,000 | +22.4% | 191,715 | +5.4% | 0.02% | +22.2% |
| Q2 2018 | $12,075,000 | +49.8% | 181,879 | +18.1% | 0.02% | +50.0% |
| Q1 2018 | $8,061,000 | +18.4% | 154,016 | +21.1% | 0.01% | +20.0% |
| Q4 2017 | $6,807,000 | +293.9% | 127,230 | +300.7% | 0.01% | +233.3% |
| Q3 2017 | $1,728,000 | -8.4% | 31,753 | -12.9% | 0.00% | 0.0% |
| Q2 2017 | $1,887,000 | -24.4% | 36,471 | -8.2% | 0.00% | -25.0% |
| Q1 2017 | $2,496,000 | +46.8% | 39,711 | +23.3% | 0.00% | +33.3% |
| Q4 2016 | $1,700,000 | -31.1% | 32,211 | -29.5% | 0.00% | -25.0% |
| Q3 2016 | $2,468,000 | +725.4% | 45,700 | +517.6% | 0.00% | +300.0% |
| Q2 2016 | $299,000 | +15.0% | 7,400 | 0.0% | 0.00% | – |
| Q1 2016 | $260,000 | -21.7% | 7,400 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $332,000 | +16.5% | 7,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $285,000 | -20.4% | 7,400 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $358,000 | +22.2% | 7,400 | -10.8% | 0.00% | 0.0% |
| Q1 2015 | $293,000 | +12.7% | 8,300 | +2.5% | 0.00% | – |
| Q4 2014 | $260,000 | -64.7% | 8,100 | -59.1% | 0.00% | -100.0% |
| Q3 2014 | $736,000 | -12.2% | 19,800 | -9.6% | 0.00% | 0.0% |
| Q2 2014 | $838,000 | -44.1% | 21,900 | -33.4% | 0.00% | -66.7% |
| Q1 2014 | $1,499,000 | +73.9% | 32,900 | +52.3% | 0.00% | +50.0% |
| Q4 2013 | $862,000 | -27.7% | 21,600 | -20.6% | 0.00% | 0.0% |
| Q3 2013 | $1,192,000 | +48.6% | 27,200 | +6.7% | 0.00% | 0.0% |
| Q2 2013 | $802,000 | – | 25,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |